Successful reperfusion in acute myocardial infarction, whether by thrombolysis or primary angioplasty, potentially results in myocardial salvage and preservation of left ventricular function, with improvement in short and long-term prognosis. The clinical efficacy of primary percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarction is limited by the risks of early reocclusion and late restenosis. Several multicenter trials have shown that stenting is effective in the prevention of abrupt coronary occlusion after threatened or acute vessel closure, better procedural success, lower acute adverse events, lower angiographic restenosis, greater improvement in coronary flow reserve and myocardial perfusion, and lower intermediate- and long-term target vessel revascularization, compared to conventional balloon angioplasty